TM6SF2 and coronary artery disorder: Indeed, variants in both PNPLA3 and TM6SF2 have also been associated with lower plasma lipid levels, both triacylglycerols and LDL-cholesterol [46], which might explain the negative relationship of these SNPs with CAD (Fig. 3b,c).